Bone Abstracts

Previous issue | Volume 5 | ECTS2016 | Next issue

43rd Annual European Calcified Tissue Society Congress

Rome, Italy
14 May 2016 - 17 May 2016

Oral Communications

Clinical trials, FGF-23 and focal osteoporosis

Previous section
Bone mass and bone strength Wnt signalling

Table of contents

Next section
Catabolism and metabolism

ba0005oc3.1 | Clinical trials, FGF-23 and focal osteoporosis

Effect of odanacatib on bone density and estimated bone strength in postmenopausal women: a CT-based sub-study of the phase 3 long-term odanacatib fracture trial (LOFT)

ba0005oc3.2 | Clinical trials, FGF-23 and focal osteoporosis

Effects of Denosumab (Dmab) on bone matrix mineralization: results from the phase 3 FREEDOM trial

ba0005oc3.3 | Clinical trials, FGF-23 and focal osteoporosis

Vitamin D supplementation reduces pregnancy chances: a randomized, placebo-controlled trial

ba0005oc3.4 | Clinical trials, FGF-23 and focal osteoporosis

The response of fibroblast growth factor-23 to teriparatide in postmenopausal osteoporosis

ba0005oc3.5 | Clinical trials, FGF-23 and focal osteoporosis

Low serum iron is associated with high serum FGF23 in elderly men: the Swedish MrOS study

ba0005oc3.6 | Clinical trials, FGF-23 and focal osteoporosis

Focal osteoporosis associated with hip fracture involves both trabecular and cortical bone; a 3D cortical bone mapping study of cases and controls using clinical CT

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

43rd Annual European Calcified Tissue Society Congress

Clinical trials, FGF-23 and focal osteoporosis

BiosciAbstracts